| Literature DB >> 26520247 |
James K Kirklin1, David C Naftel2, Francis D Pagani3, Robert L Kormos4, Lynne W Stevenson5, Elizabeth D Blume6, Susan L Myers2, Marissa A Miller7, J Timothy Baldwin7, James B Young8.
Abstract
The seventh annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes the first 9 years of patient enrollment. The Registry includes >15,000 patients from 158 participating hospitals. Trends in device strategy, patient profile at implant and survival are presented. Risk factors for mortality with continuous-flow pumps are updated, and the major causes/modes of death are presented. The adverse event burden is compared between eras, and health-related quality of life is reviewed. A detailed analysis of outcomes after mechanical circulatory support for ambulatory heart failure is presented. Recent summary data from PediMACS and MedaMACS is included. With the current continuous-flow devices, survival at 1 and 2 years is 80% and 70%, respectively.Entities:
Keywords: INTERMACS; advanced heart failure; destination therapy; mechanical support; ventricular assist device
Mesh：
Year: 2015 PMID： 26520247 DOI： 10.1016/j.healun.2015.10.003
Source DB: PubMed Journal: J Heart Lung Transplant ISSN： 1053-2498 Impact factor: 10.247